Related Experiment Video
Updated: Aug 3, 2025

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
A Case of Neuroleptic Malignant Syndrome Presenting as Anxiety
Cameron G Hanson1, Amit Chopra1
1Department of Emergency Medicine, Henry Ford Health System, Macomb, USA.
Abstract:
Neuroleptic malignant syndrome (NMS) is a rare but potentially lethal complication of dopamine antagonist use. A 34-year-old male presented to the emergency department with a chief complaint of feeling anxious for the past several days. He presented with his family who helped provide history as he had become less communicative over the preceding two days. It was revealed that the patient had a recent psychiatric hospitalization for suspected new-onset psychosis and was discharged six days prior to his presentation. It was reported that the patient was discharged with unknown psychiatric medications but stopped taking them two days prior because he felt they were increasing his anxiety. On physical examination, the patient was found to have upper extremity rigidity and appeared tremulous. A review of records revealed that the patient was discharged from inpatient psychiatric treatment on dual antipsychotic therapy. With this information, the patient met the diagnostic criteria for NMS. He was hospitalized and his symptoms resolved following treatment. Without the knowledge of antipsychotic use, the diagnosis of a serious, life-threatening condition may have been missed. Our case highlights an important but occasionally overlooked aspect of evaluating a patient in the emergency department, namely, outside chart and documentation reviewing.
Insights
Neuroleptic Malignant Syndrome (NMS), a rare condition from dopamine antagonists, can be missed if outside medical records are not reviewed. Prompt diagnosis and treatment are crucial for patient recovery.
Area of Science:
- Neurology
- Psychiatry
- Emergency Medicine
Background:
- Neuroleptic Malignant Syndrome (NMS) is a rare, life-threatening condition.
- It is a complication associated with dopamine antagonist medications.
Observation:
- A 34-year-old male presented with anxiety, decreased communication, rigidity, and tremors.
- He had recently stopped taking prescribed antipsychotic medications due to increased anxiety.
Findings:
- The patient met diagnostic criteria for NMS based on his symptoms and recent medication changes.
- Reviewing outside medical records confirmed dual antipsychotic therapy use.
Implications:
- This case underscores the importance of reviewing external patient documentation in emergency settings.
- Failure to identify antipsychotic use can lead to missed diagnoses of serious conditions like NMS.
Related Concept Videos
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Mania and Antimanic Drugs: Overview
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Drug Therapy
Antianxiety Medications
Anxiolytic Drugs: Benzodiazepines and Buspirone
Generalized Anxiety Disorder

